Eczema Trial, Recruiting (NCT06529913)

Eczema Trial, Recruiting NCT06529913 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Eczema

Printed from Voxsanity (voxsanity.com.au) — NCT06529913 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eczema

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be an adult aged 18 or over
You have a skin reaction (rash or irritation) caused by an allergy to metals
You experience body-wide allergic reactions triggered by metals
You are a healthy adult with no relevant conditions
You are able to read and sign a consent form agreeing to take part

Who may not be able to join:

Anyone under the age of 18
Women who are pregnant or currently breastfeeding
People with serious long-term kidney disease that requires treatments such as dialysis
People who have other health conditions throughout the body that are linked to metal exposure
People with certain digestive or gut conditions, such as coeliac disease, chronic inflammatory bowel disease, gut or intestinal cancers, or other skin diseases
Anyone who is unable to read, understand, or sign a written consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Angela Rizzi, MD, PhD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +390630154952

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06529913

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Eczema

Trial contact: +390630154952

More information: https://clinicaltrials.gov/study/NCT06529913

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be an adult aged 18 or over
You have a skin reaction (rash or irritation) caused by an allergy to metals
You experience body-wide allergic reactions triggered by metals
You are a healthy adult with no relevant conditions
You are able to read and sign a consent form agreeing to take part

Who may not be able to join:

Anyone under the age of 18
Women who are pregnant or currently breastfeeding
People with serious long-term kidney disease that requires treatments such as dialysis
People who have other health conditions throughout the body that are linked to metal exposure
People with certain digestive or gut conditions, such as coeliac disease, chronic inflammatory bowel disease, gut or intestinal cancers, or other skin diseases
Anyone who is unable to read, understand, or sign a written consent form

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Registry

ClinicalTrials.gov

Start date

13 January 2025

Est. completion

30 September 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Serum concentration of metals; Urinary concentration of metals; Patch test; Number of subjects with altered values of respiratory system impedance; Serum concentration of zonulin; Serum concentration of protein oxidation products

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov